← SearchPRECLINICAL DEVELOPMENT OF MMV609, A SECOND-GENERATION ATP4I, FOR MALARIA$5,072,634FY2025Defense Health AgencyDODRegents Of The University Of MinnesotaInvestigatorsView source on USAspending →